Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.47 Million shares of MRNA, which is worth approximately $210 Million. The most recent transaction as insider was on May 29, 2024, when has been sold 341 shares (Common Stock) at a price of $144.5 per share, resulting in proceeds of $49,274. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.47M
2.95% 3M change
9.83% 12M change
Total Value Held $210 Million

Stephen Hoge Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
SELL
Open market or private sale
$49,274 $144.5 p/Share
341 Reduced 0.02%
1,471,777 Common Stock
May 28 2024
BUY
Exercise of conversion of derivative security
-
610 Added 0.04%
1,472,118 Common Stock
May 15 2024
SELL
Open market or private sale
$1,912,350 $127.49 p/Share
15,000 Reduced 1.01%
1,471,508 Common Stock
May 10 2024
SELL
Open market or private sale
$30,844 $120.96 p/Share
255 Reduced 0.02%
1,486,508 Common Stock
May 09 2024
BUY
Exercise of conversion of derivative security
-
522 Added 0.04%
1,486,763 Common Stock
Apr 15 2024
SELL
Open market or private sale
$1,575,300 $105.02 p/Share
15,000 Reduced 1.0%
1,486,241 Common Stock
Mar 15 2024
SELL
Open market or private sale
$1,547,550 $103.17 p/Share
15,000 Reduced 0.99%
1,501,241 Common Stock
Mar 04 2024
SELL
Open market or private sale
$29,151 $94.34 p/Share
309 Reduced 0.02%
1,516,241 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
-
652 Added 0.04%
1,516,550 Common Stock
Feb 29 2024
SELL
Open market or private sale
$225,833 $94.57 p/Share
2,388 Reduced 0.16%
1,515,898 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
4,853 Added 0.32%
1,518,286 Common Stock
Feb 22 2024
SELL
Open market or private sale
$1,500,000 $100.0 p/Share
15,000 Reduced 0.98%
1,513,433 Common Stock
Feb 16 2024
SELL
Open market or private sale
$936,972 $88.88 p/Share
10,542 Reduced 0.69%
1,528,433 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
22,694 Added 1.45%
1,538,975 Common Stock
Feb 12 2024
SELL
Open market or private sale
$26,213 $86.23 p/Share
304 Reduced 0.02%
1,516,281 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
-
522 Added 0.03%
1,516,585 Common Stock
Jan 16 2024
SELL
Open market or private sale
$1,558,500 $103.9 p/Share
15,000 Reduced 0.98%
1,516,063 Common Stock
Dec 27 2023
SELL
Open market or private sale
$4,500,450 $100.01 p/Share
45,000 Reduced 2.86%
1,531,063 Common Stock
Dec 04 2023
SELL
Open market or private sale
$24,506 $79.31 p/Share
309 Reduced 0.02%
1,576,063 Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
-
651 Added 0.04%
1,576,372 Common Stock
Nov 29 2023
SELL
Open market or private sale
$90,664 $79.81 p/Share
1,136 Reduced 0.07%
1,575,721 Common Stock
Nov 28 2023
BUY
Exercise of conversion of derivative security
-
2,411 Added 0.15%
1,576,857 Common Stock
Nov 10 2023
SELL
Open market or private sale
$18,083 $68.76 p/Share
263 Reduced 0.02%
1,574,446 Common Stock
Nov 09 2023
BUY
Exercise of conversion of derivative security
-
522 Added 0.03%
1,574,709 Common Stock
Sep 15 2023
SELL
Open market or private sale
$1,694,850 $112.99 p/Share
15,000 Reduced 0.94%
1,574,187 Common Stock

Also insider at

AXLA
Axcella Health Inc. Healthcare
Director
Stephen Hoge

Stephen Hoge

President
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA